Page last updated: 2024-10-27

fentanyl and B16 Melanoma

fentanyl has been researched along with B16 Melanoma in 2 studies

Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Baamonde, A1
Menéndez, L1
González-Rodríguez, S1
Lastra, A1
Seitz, V1
Stein, C1
Machelska, H1
Andoh, T1
Shinohara, A1
Kuraishi, Y1

Other Studies

2 other studies available for fentanyl and B16 Melanoma

ArticleYear
A low pKa ligand inhibits cancer-associated pain in mice by activating peripheral mu-opioid receptors.
    Scientific reports, 2020, 10-29, Volume: 10, Issue:1

    Topics: Analgesics, Opioid; Animals; Bone Neoplasms; Cancer Pain; Cell Line, Tumor; Fentanyl; Hydrogen-Ion C

2020
Inhibitory effect of fentanyl citrate on the release of endothlin-1 induced by bradykinin in melanoma cells.
    Pharmacological reports : PR, 2017, Volume: 69, Issue:1

    Topics: Analgesics, Opioid; Animals; Bradykinin; Dose-Response Relationship, Drug; Endothelin-1; Fentanyl; M

2017